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Prenatal testing for HIV is a major component in many national 
strategies to prevent vertical transmission of the disease and 
reduce the burden of HIV/AIDS. Among developing nations, the 
Government of Botswana has made particularly impressive strides 
in combating the disease, achieving rates similar to those of devel-
oped nations, where the incidence of neonatal HIV has been virtu-
ally eliminated. As a result of a pioneering programme introduced 
in 2004, which uses an ‘opt-out’ approach to testing in antenatal 
care, the rate of mother-to-child transmission (MTCT) of HIV in 
Botswana has been reduced from 20.7% in 2003 to 4.8% in 2007 
(UNGASS Indicator Data, 2007). Despite the obvious individual and 
societal gains from such an approach, both in Botswana as well 
as in other countries where similar policies have been adopted, 
there remain unsettled issues surrounding prenatal HIV testing. 
Tensions surrounding the rights of society, mothers-to-be and the 
unborn raise difficult ethical and legal questions regarding decision 
making, respect for autonomy, confidentiality, public health and in-
dividual rights that cannot be ignored. This article is based on the 
assumption that the government’s capacity to deal effectively with 
HIV/AIDS is inherently connected with larger societal, legal, policy 
and contextual issues. These issues appear to be insufficiently ap-
preciated in Botswana, even though their consideration is essen-
tial if the country is to align its practices with existing national laws 
as well as international conventions to which it is a signatory.
The vulnerability of girls and young women to HIV/AIDS has 
been documented in many studies and discussed at various Unit-
ed Nations forums. Most states agree that young people have the 
right to develop their capacities, to access a range of services and 
opportunities, to live, learn and earn within a safe and supportive 
environment, and to participate in decisions and actions that af-
fect them.1 Botswana has a high HIV prevalence among pregnant 
women (33.4% in 2007) and provides a free prevention of MTCT 
(PMTCT) service. Currently nearly all pregnant women (95%) 
have antenatal care (ANC).2 Uptake of antenatal testing was low 
from 1999 through 2003. In 2004, Botswana’s President declared 
that HIV testing should be routine but not compulsory in medical 
settings.3 A rights-based understanding of participation in theory 
and practice is crucial. The relationships between participation 
and decision making in prenatal testing and access to information, 
recourse to treatment and accountability, among others, are still 
uncertain issues in Botswana.
The situation in Botswana is controversial because few or-
ganisations have any understanding of how the rights of women 
living with HIV/AIDS are violated.4 The success of the PMTCT 
programme has made Botswana an example for other African na-
tions. However, antiretroviral treatment (ART) alone cannot solve 
Botswana’s devastating HIV and AIDS crisis. In his address at 
the 17th International AIDS Conference in Mexico in 2008, former 
President Mogae stressed that while the government must remain 
committed to Botswana’s comprehensive treatment programme, 
hopes of ever overcoming AIDS in Botswana lie in controlling 
transmission: ‘Prevention of new infections should be our priority 
number one, priority number two and priority number three.’5
PMTCT is one of the key strategies for halting the spread of HIV. 
A national PMTCT programme is in place and is functioning well. 
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Its objective was to reduce MTCT of HIV to 20% by 2006 and to 
10% by 2009.6 Routine testing, according to which all patients are 
tested unless they opt out, as recommended by UNAIDS and the 
World Health Organization (WHO), was introduced in Botswana 
in 2004. One key concern is prenatal testing. It has been rightly 
suggested by Staurt and Behets7 that in settings marked by pov-
erty, weak healthcare and inadequate civil society infrastructure, 
gender inequalities, and persistent stigmatisation of people with 
HIV/AIDS, opt-out testing policies may become split from human 
rights ideals that first motivated calls for the universal access to 
AIDS treatment. Prenatal testing, a crucial element in this process, 
is a substantially neglected subject in empirical research, human 
rights monitoring and ethical scrutiny in underdeveloped countries, 
including Botswana. The country’s testing policy poses potential 
threats to patient rights concerning consent, confidentiality and 
counselling.
HIV prenatal testing: an ethical and 
human rights perspective
According to the UNAIDS/WHO Policy Statement (the Policy), the 
cornerstones of an HIV testing scale-up must include protection 
from stigma and discrimination as well as assured access to in-
tegrated prevention, treatment and care services. The conditions 
of testing must be anchored in a human rights approach which 
protects rights and pays due respect to ethical principles.8 The 
Policy introduced the practice of routine, provider-initiated ‘opt-out’ 
testing as one of several preventive strategies in use, as shown 
in Table 1.
Informed consent under the Policy
According to the Policy, informed consent requires awareness of 
the following:
• the clinical and the prevention benefits of testing
• the right to refuse
• the follow-up services offered
• in the event of a positive test result, the need to inform anyone 
with an ongoing risk who would otherwise not suspect that he/
she was being exposed to HIV infection.
In settings with provider-initiated offers of testing, whether for 
purposes of establishing HIV status as part of an individual’s clini-
cal care and treatment offering prenatal ART to pregnant women 
found to be HIV positive, patients must retain the right to refuse 
testing, i.e. to ‘opt out’ of an offer of systematic testing.9 The Policy 
makes it clear that opt-out testing can only take place in a setting 
where mechanisms exist for counselling and referral for medical 
and psychosocial support after testing. The pre-test counselling 
may be cut short (compared with voluntary counselling and testing 
(VCT)), but should be sufficient to provide informed consent.
Ensuring a rights-based approach
Globally, HIV testing is a prerequisite to scaling up the response to 
AIDS and access to treatment. It must be grounded in sound pub-
lic health practice and also respect, protect and fulfil human rights 
norms and standards. The voluntariness of testing must remain 
at the heart of all HIV policies and programmes, both to comply 
with human rights principles and to ensure sustained public health 
benefits. According to a UNAIDS report,10 the following key factors, 
which are mutually reinforcing, need to be addressed simultane-
ously:
• ensure an ethical process for conducting the test, defining 
the purpose and benefits of testing; assurances of linkages be-
tween the sites where the test is conducted; confidentiality of all 
medical information
• address the implications of a positive test result, such as ac-
cess to sustainable treatment and care
• erase HIV/AIDS-related stigma and discrimination at all lev-
els, notably within healthcare settings
• ensure a supportive legal and policy framework within which 
the response is scaled up, safeguarding the human rights of 
those seeking services
• ensure adequate post-diagnostic infrastructure.
Botswana prenatal HIV testing policy in 
global perspective
Prior to the devastating effects of HIV/AIDS, Botswana was on 
track to significantly reduce child mortality in keeping with the 
Millennium Development Goals (MDGs) to which it is party.11 In 
the early 1990s, fewer babies died at birth or within 5 years of 
birth than at the end of the decade. From the mid-1990s, child 
mortality rates increased to levels experienced in the 1970s. HIV 
prevalence among pregnant women attending antenatal clinics 
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Table 1. HIV testing practice in clinical settings
Voluntary counselling and testing (VCT) Client-initiated testing to learn HIV status provided through VCT
Diagnostic HIV testing Is indicated whenever a person shows signs or symptoms that are consist-
ent with HIV-related disease or AIDS to aid clinical diagnosis and manage-
ment 
Routine provider-initiated offer of HIV testing of 
pregnant women
Should be seen in the context of pregnancy, to facilitate an offer of 
antiretroviral prevention of mother-to-child transmission in clinical and 
community-based health service settings where HIV is prevalent and ART 
is available (for those who are asymptomatic)
Mandatory HIV screening UNAIDS/WHO support mandatory screening for HIV and other blood-borne 
viruses of all blood that is destined for transfusion or for manufacture of 
blood products
increased from 13.8% in 1992 to 35.4% in 2002. It is estimated 
that 40% of infants born to HIV-positive mothers who do not enrol 
for PMTCT are infected with HIV. Infant deaths closely follow the 
AIDS prevalence index. The under-5 mortality rate has also in-
creased since 1996.12 After routine testing began, the percentage 
of infected women (delivering in the regional hospital) who knew 
their HIV status increased from 47% to 78% and the percentage 
receiving PMTCT interventions increased from 29% to 56%. ANC 
attendance and the percentage who disclosed their HIV-positive 
status remained stable. Research indicates that ANC clients sup-
ported the policy.2,13
Routine testing was more accepted than voluntary testing and 
led to substantial increases in test participation and PMTCT inter-
ventions without detectable adverse consequences. Botswana’s 
stable and relatively well-resourced government has provided ex-
tensive funding to combat the HIV epidemic and started Africa’s 
first national programme for PMTCT of HIV in 1999, providing 
short-course zidovudine (AZT) for mothers and infants and infant 
formula at no cost to clients. It has the potential to reduce vertical 
transmission from 35 - 40% to 5 - 10%.3,14
Ethical and human rights issues in the 
opt-out approach: unmet challenges
Test results between November 2006 and February 2007 indicate 
that less than 4% of babies born to HIV-positive mothers were 
infected, a rate comparable to those in the USA and Western Eu-
rope.15 However, ethical and human rights questions surrounding 
opt-out policies in prenatal cases, and the impact of such policies 
on individuals and communities, largely remain unanswered. The 
subject revolves around the conflict between human rights and the 
pursuit of public health goals, and the potential benefits and risks 
for unborn children and mothers-to-be. In a public meeting in Bot-
swana, Bonela, a local NGO, discussed the ethical issues involved 
in HIV testing.16 Timely diagnosis, it was stated, can allow access 
to ART for opportunistic infections or longitudinal care. Horizon-
tal HIV transmission can be prevented through knowledge of HIV 
status and behaviour change, and vertical transmission through 
screening and subsequent intervention for HIV-positive pregnant 
women. Furthermore, HIV/AIDS awareness and risk reduction 
may result in those who test HIV negative. Despite the potential 
benefits, the meeting reached the consensus that compulsory HIV 
testing, even in a high-prevalence country such as Botswana, is 
ethically unacceptable. While weighing up the risks and benefits, 
the discussion group concluded that routine testing for HIV/AIDS 
in the context of overwhelming public health hazards is ethically 
defensible on condition that individual rights are protected and the 
negative consequences of being tested (and found HIV positive) 
are minimised by appropriate social and institutional support ser-
vices.16
The subject, however, demands more empirical research, hu-
man rights monitoring and ethical scrutiny, not yet advanced in 
Botswana. For instance, testing has been available in Botswa-
na’s public health system since the mid-1990s, but there have 
been barriers leading to reluctance among patients and provid-
ers to discuss HIV. A shortage of trained counsellors, concerns 
about confidentiality in small communities, results taking several 
weeks to return, and a dearth of population mobility lead to many 
unclaimed results. HIV testing for PMTCT was initially offered 
by midwives at routine ANC, who received counselling training 
and were expected to weigh risks and benefits of testing with 
each client. However, many women were not offered, and most 
women refused, testing. In late 2002, lay counsellors (secondary 
school graduates with 4 weeks of training) were employed to pro-
vide dedicated counselling services for PMTCT in public clinics. 
Testing uptake improved somewhat, but many women remained 
untested and untreated.17
According to Staurt and Behets,7 like the Botswana policy, the 
UNAIDS/WHO policy clearly aims at producing a win-win situa-
tion in which governments can pursue public health goals more 
aggressively without compromising the rights of the individual. 
But the complexities associated with a genuine consideration of 
human rights, particularly in resource-poor countries, are often 
downplayed by advocates of the new routine testing policies. It 
is a well-documented fact that the epidemic has had a gender 
bias, more especially in African regions. Prejudicial cultural and 
traditional practices directly influence women’s decision making in 
sexual and reproductive health issues as well. Increasing poverty 
among single female-headed households and the rising incidence 
of violence, including rape, are other contributing factors.18
Informed consent, participation and 
decision-making power in prenatal 
testing
Ethical considerations are wider in prenatal testing. One of the 
main ethical obstacles is the stipulation that voluntariness must 
be central to all HIV policies. The condition is not fulfilled simply by 
offering the patient the right to refuse. Right of refusal or the opt-
out approach balances autonomy with medical practice and meets 
ethical standards of informed consent.7
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Table 2. Prenatal testing
Year 1992 2002* 2003 2004 2005 2006 2007 2008† (Oct - Dec quarter)
No./% of preg-
nant women 
13.8 35.4 52 75 92 83 94 A total of 11 875 new ANC 
clients were recorded
*The programme became available in every public antenatal clinic.
†Over 11 000 under PMTCT, 5 March 2009. Daily News, Gaborone, Botswana.
Sources: Botswana 2006 HIV Sentinel Surveillance data; Botswana FY Country Operational Plan (COP) 2008.
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Participation in prenatal HIV testing is key to the right to health, 
as are other human rights. However, participation can mean very 
different things to different role players. Testing is fundamental to 
both prevention and treatment of HIV. Efforts to increase testing 
have recently been extended to the provision of ‘opt-out’ or rou-
tine testing, where the healthcare provider rather than the client 
initiates the test. Testing kindles beneficial behavioural change19 
and opens access to regulated resources and services, such as 
PMTCT.20 In this scenario, HIV testing is offered routinely to all 
patients attending a particular healthcare facility, such as an ANC, 
even though they are asymptomatic. The emphasis is shifted from 
client-initiated (as in VCT) to provider-initiated testing. The pro-
cess is still voluntary, with the option to refuse (opt out). It may also 
decrease the stigma associated with choosing to have a test in as 
much as everyone is having it offered irrespective of perceived 
risk.20,21 It is still a matter of concern calling for further studies. 
What effect the HIV opt-out policy has on the popularity of the 
original non-related services (the proportions accepting/declining 
HIV testing; proportion receiving results of the test; proportion at-
tending further HIV-related services if positive; and overall attend-
ance rates at the health facility before and after the introduction of 
an opt-out policy) has not been adequately assessed.3 As routine 
testing policies are deemed potentially coercive, provider-initiated 
approaches are gaining popularity; counselling may no longer be 
practised, people may be dissuaded from visiting their doctors for 
fear of being tested, and this policy may also increase testing-
related partner violence.22 It is important to improve awareness 
of individual rights and mitigate obstacles associated with imple-
mentation of the policy in Botswana.23 According to Clark,24 one of 
a number of physicians at Princess Marina Hospital in Botswana, 
the main public hospital in the capital of Gaborone, even with mass 
education most women refuse to be tested. However, the situation 
seems to be different in the case of prenatal testing.2,13 According 
to Clark: ‘Mandatory HIV testing, and when necessary, mandatory 
treatment of all pregnant women in Botswana is both a necessary 
and a vital part of a broader comprehensive strategy for preventing 
the spread of AIDS in sub-Saharan Africa.’24
The decision-making process
The rates of HIV infection among pregnant women and the irregu-
lar uptake of PMTCT services suggest that not many couples are 
making responsible reproductive health choices. This is partially 
explained by the disproportionate responsibility for family health 
choices and child care that women carry.25 The legal system in 
the country and cultural norms reinforce gender inequality by giv-
ing men control over productive resources such as land, through 
marriage laws that make women subject to their husbands, and 
inheritance customs that make males the principal beneficiaries of 
family property. This is still the trend despite the fact that country 
ratified in 1996 the Convention on the Elimination of all forms of 
Discrimination Against Women (CEDAW). Such resolutions have 
far-reaching consequences for the rights of women, as well as 
their decision-making power at the time of prenatal testing.
Another crucial concern is the lack of involvement of male part-
ners in every aspect of HIV management. In any society, men play 
a significant role in women’s sexual and reproductive decisions. 
According to UNICEF statistics, the involvement of men in pro-
grammes such as PMTCT in Botswana is only10%. Field research 
by Nair and Rakgoasi18 confirms that voluntary testing services do 
not attract men in significant numbers. The counselling services 
offered at the ANCs to motivate men and women to be tested and 
to pursue appropriate preventive measures or treatment are insuf-
ficient, particularly for men. The entire management of pregnancy 
and childbirth is considered the exclusive domain of women. Men 
generally do not accompany wives or partners to ANCs or other 
health facilities where HIV-related services are available. There 
are a number of barriers in the community that prevent men’s par-
ticipation and increased role in ANCs and related services. They 
range from a lack of motivation, men’s bias against service provid-
ers and strong traditional stereotypes and misconceptions about 
the different roles of men and women in reproductive health, to 
class differences between the service providers and men.18 Ac-
cording to Charity Kgotlafela, Vision 2016 Council Publicity Man-
ager, the negative impact of the HIV/AIDS epidemic runs across 
all Vision 2016 Pillars, especially the Vision Pillar 6 – Botswana to 
be ‘A Moral and Tolerant Nation’; many women still feel that nega-
tive social attitudes towards the status and role of women have not 
been completely removed from society.26
Right to information and knowledge on 
ANC, PMTCT, VCT, etc.
According to research reports18 based on focus group discussions, 
women in Botswana are aware of the need for antenatal check-ups, 
including testing and treatment for PMTCT, from seeing other wom-
en attend health facilities and from health talks and posters at health 
centres, as well as television and print media. In their own words: 
‘We hear at kgotla meetings, public meetings, freedom squares for 
different political parties and from Parliament members when they 
visit our village. Even the President and Chiefs talk about it.’
Men not only tend to rely on their partners as sources of in-
formation on testing and prevention programmes, they also use 
their partner’s HIV test results to infer their own HIV status. In any 
rural society, Africa in particular, traditional leaders and chiefs play 
a decisive role in influencing people’s attitudes and perceptions. 
The level of knowledge among these leaders is therefore crucial 
for the success of the HIV management programme. As traditional 
leaders, chiefs have a lot of influence among the rural public.18 
However, there is very little evidence to suggest that traditional 
leaders are any more knowledgeable than the rest of the popula-
tion, or that they are able to stand up and challenge stereotypes 
and misconceptions about modern testing practices.
Attitudes and perceptions towards 
testing
Routine testing appears to be widely supported and may reduce 
barriers to testing in Botswana. Eleven months after introduction of 
the ‘opt-out’ policy in Botswana in 2005, a cross-sectional, popu-
lation-based study25 of 1 268 adults from five districts in Botswana 
to assess attitudes toward routine testing revealed that most par-
ticipants (81%) reported being extremely in favour of routine test-
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ing. The majority believed that this policy would decrease barriers 
to testing (89%), HIV-related stigma (60%), and violence toward 
women (55%), as well as increase access to ART (93%). At the 
same time, 43% of participants believed that routine testing would 
lead people to avoid going to the doctor for fear of testing. The 
prevalence of self-reported HIV testing was 48%. In the context 
of potential human rights infringements, few individuals reported 
violence (1%), discrimination (2%) or a breach of confidentiality by 
healthcare workers (5%) associated with VCT or routine testing. In 
addition, approximately two-thirds of participants who were tested 
by either routine testing or VCT felt that they could not refuse the 
test, suggesting that the voluntary nature of both routine testing 
and VCT is not fully understood.25 In 2009 a report by National 
Council for AIDS stated that a significant proportion of the new 
ANC clients refuse the test.27 In addition, the number of women on 
highly active antiretroviral therapy (HAART) at delivery continues 
to be high (901 for the October - December quarter).27,28 This is the 
highest since 2007, according to the Council, which may suggest 
an increasing number of pregnancies among women on HAART. 
These findings accentuate the importance of implementing HIV 
testing policies with measures in place to ensure informed con-
sent, protection of confidentiality, and protection of women from 
gender-based violence related to testing. Nevertheless, the testing 
process is still being viewed as women’s domain, with a very small 
role for men. A woman remarked: ‘When it comes to ANC, most 
men do not know about [it]. It is a woman’s secret and so she will 
handle it alone. I think if you take your partner when you go for 
ANC, he will understand what is going on.’26
Some women may be reluctant to be tested for HIV, to follow an 
ART regimen if found to be positive, or to adopt health behaviours, 
such as formula feeding for babies, which might expose their posi-
tive infection status to their partners. In a society where marriage 
as a social institution is not strong, it is not strange to find that 
married women do not want to risk their married state. Accord-
ing to the Mashi Study, for an African mother living with HIV, the 
decision not to breastfeed her child is problematic. The lack of 
access to clean water and formula, and the societal pressures to 
breastfeed only make the decision more difficult.28 According to 
another report by NACA, new infant infections are estimated from 
prevalence among pregnant women and the rate of MTCT, which 
is dependent on infant feeding practices and prophylactic cover 
with ARVs.29 According to the Ministry of Health, without interven-
tion 35 - 45% of babies exposed to the HIV virus through vertical 
(mother-to-child) transmission will be infected. MTCT occurs 15 - 
20% through breastfeeding. Of HIV-positive women, 65% fed their 
infants formula from birth (as of 2005).30 Under PMTCT formula 
is provided for women who choose formula feeding. However, 
women may opt out if they desire.29,31 Problems such as partner 
violence associated with HIV testing have also been identified, for 
women in particular.24,32 By marital status, the highest prevalence 
(42%) was among women living with partners while the lowest 
(30.2%) was among married women.30
Fears have been expressed with the change in emphasis to 
provider-initiated testing, that the autonomy (the individual human 
right) of the patient to freely decline or accept testing could be 
undermined. The need to comply with the authority of health staff, 
a lack of time to consider a decision in favour of testing, and the 
strong normative message to ‘get tested’ may all contribute to un-
dermining patient autonomy.7  If individuals perceive that they have 
lack the freedom to decline a test at a health facility, they may ei-
ther avoid the facility altogether or decline those services normally 
attached to HIV testing.
Concern has also been raised that in practice a routine offer of test-
ing may effectively become routine HIV testing, with erosion of pre-
test counselling. It is argued that this would undermine the principles 
advocated by both WHO and UNAIDS, namely consent, counselling, 
and confidentiality (‘the 3 Cs’), and so violate human rights.20,33
Addressing HIV-related stigma should be an integral part of 
HIV testing policies in Botswana, including measures to protect 
those affected by discrimination in healthcare, work, and other 
settings. Policies that target HIV-related stigma may also prevent 
fears of being tested. Botswana already has several innovative 
programmes in place aimed at addressing stigma directly, such 
as media campaigns. The public testing of Ex-President Festus 
Mogae and other national leaders, and the annual ‘Miss HIV Stig-
ma Free’ competition, illustrate a moral boost the masses urgently 
needed.34 However, a deeper understanding of the dimensions of 
disease-related stigma and the mechanisms by which it reinforces 
and generates social inequalities related to gender, ethnicity, and 
class, is still required.35
Testing policy and right to personal 
autonomy/reproductive choices for 
women: upcoming debates
An accommodation between personal freedom and the exercise 
of state authority is always delicate.  It is particularly challenging 
when a public health intervention such as Botswana’s ‘opt-out’ 
testing policy may undermine a woman’s right to reproductive 
choices and to autonomous decision-making. A small number of 
research reports have raised the issue of abortion as one choice a 
woman might make in light of her HIV status. Unwanted pregnan-
cy among HIV-positive women is a reality that is hardly discussed. 
Policies that permit emergency contraception and voluntary, safe, 
legal abortion could, in settings where ‘opt-out’ programmes en-
courage pregnant women to be tested, offer a meaningful choice 
to those who do not wish to continue the pregnancy in light of 
their HIV status.4 Since the 2006 Toronto International AIDS Con-
ference, an increasing number of organisations have spoken out 
about the need to respect the reproductive rights of women living 
with HIV/AIDS.36 Strikingly, during the International Conference on 
AIDS in Mexico in 2008, abortion was presented as an obstacle 
for women living with HIV. While voluntary pregnancy termination 
was scarcely addressed at previous AIDS conferences as a policy 
issue, several speakers pointed out the need to include abortion 
care within the scope of reproductive rights.
It is being argued that a woman’s indecision to undergo prenatal 
testing manifests violation of her civil rights because it indicates 
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her lack of autonomy on matters relating to her sexual and re-
productive health.4 The right of women living with HIV to become 
mothers has definitely advanced in recent years – she has a right 
to bear children, to use assisted conception and to adopt children. 
Interestingly, the issues were not discussed at the recent Interna-
tional Conference on AIDS in Botswana. The right of HIV-positive 
women to avoid unwanted pregnancies has not been accepted as 
an issue so far.  It is submitted, however, that debates over these 
issues have just begun in the global forum and the author there-
fore leaves this issue open, while reserving her personal view, and 
believing that the state has the right to intervene in the matter of 
the life of an unborn child regardless of the opinion of the parent 
and that the opt-out policy is the most benign form of intervention.
Why women do not register for PMTCT 
and related care
HIV-related stigma and denial was also a major barrier to women 
accessing services: ‘People are still reluctant to come forward to 
be tested. They don’t come forward because of the fear of dis-
crimination and the stigma associated with HIV. And unless you’re 
tested, you don’t know whether or not you’re positive and therefore 
might benefit from treatment.’ 37
HIV stigma was identified by government and press sources as 
one possible impediment to testing and to the success of the new 
ART programme. Individuals very often shun testing and treat-
ment facilities to avoid potential stigma and discrimination.38 Some 
women reported that it is not easy to participate in PMTCT pro-
grammes because people will become aware of their HIV-positive 
status when they are seen collecting milk at the health facility and 
may scoff at or even isolate them. Many women therefore decide 
to breastfeed so that people will think that they are not affected. 
Some women fail to register with the programme because health 
workers do not follow up after testing to find out if they are mentally 
strong enough to reveal their status to their relatives (partners, 
mothers or next of kin) or to offer needed counselling. In such situ-
ations, women decide to remain silent and breastfeed their chil-
dren even if they have registered and followed other procedures.39
Rights of the unborn
 The unborn, merely on account of their non-existence in the physi-
cal world, are not beyond the protection of human rights. Their sta-
tus under law, although controversial, is unique as well, and in the 
context of prenatal testing may create ethical tensions between 
the rights of a pregnant woman to determine what is done to her 
body (autonomy) and obligations to the well-being of an unborn 
child (beneficence).
Botswana’s public health system caters well to the needs of chil-
dren. It provides prenatal care services that cover nutrition and 
health education for pregnant women. It also provides a fully fund-
ed nationwide PMTCT programme that includes infant formula as 
a substitute for breastmilk for HIV-positive mothers. But the limits 
of state protection for children may well be stretched further in 
the case of HIV/ AIDS. Why, for instance, should the state allow 
a woman who tests positive for HIV to remain ignorant of her HIV 
status if she so desires, when ignorance may result in her not re-
ceiving prenatal ART and in the prolongation of risk of MTCT for 
her newborn through breastfeeding?40
International guidelines regarding clinical care and medical re-
search oblige health professionals to adhere to the principles of 
respect for persons (autonomy), beneficence, non-maleficence 
(do no harm), and justice.41 These may be considered what Ross42 
would describe as prima facie or conditional duties that must be 
weighed against each other to arrive at a course of right conduct 
in any given situation. Depending on context, the obligations under 
one duty may ‘trump’ obligations under another. With regard to 
the principle of autonomy, courts have consistently agreed that a 
patient’s right to self-determination is not absolute, permitting the 
informed consent requirement to be overruled in fewer than five 
generally recognised circumstances: a public health emergency, 
a medical emergency, the incompetent patient, the therapeutic 
privilege, and the patient waiver.43 Botswana’s national response 
to the HIV epidemic in general and to the need to reduce the in-
cidence of MTCT of HIV in particular, has been in recognition of 
a public health emergency. In this context, the state has based 
its obligations on a moral principle of ‘beneficence’, the obligation 
to maximise the well-being of its citizens. In consideration of this, 
and given that abortion is illegal in Botswana (i.e. the ‘rights’ of 
an unborn child are protected by the state), it can be argued that 
every child, born or unborn, has a right to expect state protection 
from the risk of HIV infection. Is it not in the interest of the unborn 
child and, on a broader scale, in the interest of public health, that 
the state demand that pregnant women be informed about their 
HIV status and the options available to them to protect their chil-
dren? Secondly, men influence their spouses’ reproductive health 
choices. To facilitate informed choices on such critical issues as 
HIV testing, enrolment for PMTCT and breastfeeding, they should 
also participate in prenatal education with their spouses. Men’s 
involvement is critical because many women do not have full con-
trol over decisions concerning their health and that of their babies. 
About 60% of Batswana mothers have their first child at 15 - 19 
years of age, when they are still dependent on others and may be 
unable to make responsible reproductive health choices.44
Conclusion
Initially slower, the programme made rapid progress in 2004 and 
2005 and continues to register a high record. This suggests that 
there may be widespread support for routine HIV testing in Bot-
swana, a finding supported by recent increases in treatment up-
take, but such support remains largely unexamined in the empirical 
literature. Routine testing holds significant promise for the preven-
tion and treatment of HIV/AIDS in Botswana and elsewhere. While 
testing is central, its process demands a supportive environment 
that follows ethical considerations and respects individual rights. 
Given the ethical and human rights concerns that are raised by 
HIV testing policies, particularly an ‘opt-out’ policy such as that 
in force in Botswana, special safeguards must be put in place to 
ensure that patients have all the information necessary to make an 
informed and free decision about being tested, that women have 
adequate and readily available protection against violence related 
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to their HIV status, and that information relating to their positive 
status will be kept confidential to the fullest extent possible, in ac-
cordance with international codes and conventions.
It is suggested that in settings marked by poverty, weak health-
care and civil society infrastructures, gender inequalities, and per-
sistent stigmatisation of people with HIV/AIDS, opt-out policies 
may become disconnected from the human rights ideals that first 
motivated calls for universal access to AIDS treatment. We leave 
open the ethical question of whether opt-out policies should be 
implemented, and we recommend that whenever routine HIV test-
ing policies are introduced in resource-poor countries, their effect 
on individuals and communities should be the subject of empirical 
research, human rights monitoring and ethical scrutiny.
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